Modern CNS Drug Discovery

Microdosing Psychedelics as a Promising New Pharmacotherapeutic

This book chapter (2021) discusses the state of the art regarding microdosing psychedelics. Microdosing is well tolerated and produces subtle effects that can be beneficial in specific domains. But studies are currently only done with very small sample sizes and healthy volunteers. Double-blind studies with patient populations (including those with ADHD) are needed.

Published

June 17, 2021

Journal

Modern CNS Drug Discovery

Authors

Kuypers, K. P. C.